We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+9.34%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$9.03B
AUM Growth
+$6.6B
Cap. Flow
+$1.53B
Cap. Flow %
16.94%
Top 10 Hldgs %
64.29%
Holding
5,395
New
546
Increased
3,017
Reduced
1,240
Closed
466

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$487M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$48.2M
3
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$29.4M
4
EFA icon
iShares MSCI EAFE ETF
EFA
+$28.9M
5
MSFT icon
Microsoft
MSFT
+$27.7M

Top Sells

Rank Stock Value
1
VXX icon
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
+$51.8M
2
VOO icon
Vanguard S&P 500 ETF
VOO
+$38.5M
3
SOXL icon
Direxion Daily Semiconductor Bull 3X ETF
SOXL
+$32.6M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$21M
5
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$16.6M

Sector Composition

Rank Sector Weight
1 Technology 6.25%
2 Industrials 4.6%
3 Consumer Discretionary 4.31%
4 Healthcare 4.26%
5 Financials 3.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CNCE
2201
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$297K ﹤0.01%
30,218
+25,104
+491% +$247K
FMNB icon
2202
Farmers National Banc Corp
FMNB
$970M
$296K ﹤0.01%
27,086
+20,753
+328% +$234K
LRNZ icon
2203
TrueShares Technology AI & Deep Learning ETF
LRNZ
$42.7M
$296K ﹤0.01%
+7,525
New +$275K
QTTB icon
2204
Q32 Bio
QTTB
$458M
$296K ﹤0.01%
1,532
+987
+181% +$221K
AOSL icon
2205
Alpha and Omega Semiconductor
AOSL
$916M
$295K ﹤0.01%
23,020
+17,388
+309% +$210K
CODX
2206
Co-Diagnostics
CODX
$5.49M
$295K ﹤0.01%
724
+681
+1,584% +$350K
HLT icon
2207
Hilton Worldwide
HLT
$72.2B
$295K ﹤0.01%
3,459
-1,571
-31% -$131K
KYNB
2208
Kyntra Bio
KYNB
$28.5M
$294K ﹤0.01%
286
-146
-34% -$157K
PHM icon
2209
Pultegroup
PHM
$24.9B
$293K ﹤0.01%
6,327
-9,389
-60% -$402K
TMDX icon
2210
Transmedics
TMDX
$3.11B
$293K ﹤0.01%
21,235
+17,339
+445% +$297K
DTP
2211
DELISTED
DTE Energy Company 2019 Corporate Units
DTP
$293K ﹤0.01%
6,499
+6,199
+2,066% +$279K
EWZ icon
2212
iShares MSCI Brazil ETF
EWZ
$8.55B
$292K ﹤0.01%
10,548
-1,926
-15% -$59.1K
RBBN icon
2213
Ribbon Communications
RBBN
$377M
$292K ﹤0.01%
75,410
+62,150
+469% +$262K
WLDN icon
2214
Willdan Group
WLDN
$1.29B
$292K ﹤0.01%
11,443
+8,513
+291% +$229K
NVO
2215
Novo Nordisk
NVO
$205B
$291K ﹤0.01%
8,372
+7,952
+1,893% +$265K
P
2216
Everpure Inc
P
$39B
$290K ﹤0.01%
18,846
+18,127
+2,521% +$296K
STOR
2217
DELISTED
STORE Capital Corporation
STOR
$290K ﹤0.01%
10,555
-11,970
-53% -$304K
CVNA icon
2218
Carvana
CVNA
$81B
$289K ﹤0.01%
6,465
-21,105
-77% -$748K
GORO icon
2219
Goldgroup Mining Inc.
GORO
$211M
$289K ﹤0.01%
84,697
+59,879
+241% +$244K
FL
2220
DELISTED
Foot Locker
FL
$288K ﹤0.01%
8,711
-11,538
-57% -$352K
HXL icon
2221
Hexcel
HXL
$7.74B
$287K ﹤0.01%
8,560
+1,199
+16% +$48.4K
UFPT icon
2222
UFP Technologies
UFPT
$2.48B
$287K ﹤0.01%
6,917
+5,489
+384% +$237K
PACK icon
2223
Ranpak Holdings
PACK
$479M
$286K ﹤0.01%
29,955
+25,657
+597% +$228K
XP icon
2224
XP
XP
$8.18B
$286K ﹤0.01%
6,858
-18,367
-73% -$839K
AKTS
2225
DELISTED
Akoustis Technologies Inc
AKTS
$285K ﹤0.01%
34,930
+28,490
+442% +$230K
87 88
89
90 91

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return

Tower Research Capital (TRC)'s Q3 2020 Portfolio in Review

As of Q3 2020, Tower Research Capital (TRC) held 5,395 positions worth $9.03B, up 271% from $2.44B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Tower Research Capital (TRC) deployed $1.53B of net new capital in Q3 2020, opening 546 new positions and adding to 3,017 existing holdings. Its largest new stake was iShares Biotechnology ETF: 34,723 shares worth $4.7M.

By sector, the portfolio is most concentrated in Technology at 6.3% of assets, down from 12% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $38.5M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2020 buy was iShares Biotechnology ETF: 34,723 shares worth $4.7M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2020, an estimated $487M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $38.5M.
  • Tower Research Capital (TRC) fully exited iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2020, selling an estimated $51.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 64% of its $9.03B portfolio in Q3 2020.
  • Tower Research Capital (TRC) opened 546 new positions and closed 466 in Q3 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 271% quarter-over-quarter to $9.03B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2020, filed 16 Nov 2020.